Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study

Srđan Verstovšek(Unknown), Alessandra Iurlo(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Bruce Bank, Gabriela Borsaru, Jean‐Jacques Kiladjian(Délégation Paris 5), Francesco Passamonti(University of Milan), Andes Broliden, Donal P. McLornan(King's College London), David Lavie(Hadassah Medical Center), Mette Brabrand, Nicola Cascavilla, Aaron T. Gerds(Cleveland Clinic), Yeow Tee Goh(Singapore General Hospital), Eloise Beggiato, Miklós Egyed(Somogy Megyei Kaposi Mór Oktató Kórház), Maria Giraldo Castellano, Anna Angona(Hospital Del Mar), Jun Kawashima(Gunma University), Ruben A. Mesa(Atrium Health Wake Forest Baptist), Benjamin Carpentier, María Laura Fox(Vall d'Hebron Hospital Universitari), Soo‐Mee Bang(Seoul National University), Fiorenza Barraco(Hôpital Lyon Sud), Alessandro M. Vannucchi(Azienda Ospedaliero-Universitaria Careggi), Claire Harrison(Guy's and St Thomas' NHS Foundation Trust), Andrew C. Perkins(Monash Medical Centre), Andrew Kuykendall(Moffitt Cancer Center), Sunhee Ro(Apple (Israel)), Veronika Buxhofer‐Ausch, Haifa Kathrin Al‐Ali(University Hospital in Halle), Björn Andréasson(NU Hospital Group), Nikki Granacher(Ziekenhuisnetwerk Antwerpen Stuivenberg), Nathalie Cambier, Fleur Samantha Benghiat, Sebastian Grosicki(Medical University of Silesia), Vikas Gupta(Indian Institute of Technology Kanpur), Massimiliano Bonifacio(University of Verona), Barbara Klencke, Rosa Ayala, Sung‐Eun Lee(The Catholic University of Korea Seoul St. Mary's Hospital), Andrei Braester(Western Galilee Hospital), Sung‐Soo Yoon(Seoul National University Hospital), Adi Shacham Abulafia(Tel Aviv University), Marianna Caramella, Rafe Donahue, Claire Bories(Guy's and St Thomas' NHS Foundation Trust), Luminita Ocroteala, Mihaela Lazaroiu
The Lancet
January 1, 2023
Cited by 181


Related Papers